期刊文献+

基于TLR4/NF-κB/MAPK信号通路探讨大黄灵仙方对胆管细胞炎性反应的影响效果 被引量:3

Analysis of Dahuang Lingxian Formula(大黄灵仙方)Regulating and Controlling TLR4/NF-κB/MAPK Signaling Pathway to Affect Inflammatory Response of Bile Duct Cells
下载PDF
导出
摘要 目的通过观察大黄灵仙方调控TLR4/NF-κB/MAPK信号通路相关因子基因及蛋白的影响,探讨其对胆管细胞炎性反应的作用。方法采用大鼠胆总管注射脂多糖(lipopolysaccharide,LPS)构建原发性胆管结石胆管慢性炎症状态,取大鼠肝内胆管内皮细胞,通过qPCR技术同时结合使用信号通路阻断剂,观察胆管细胞炎性状态下TLR4/NF-κB/MAPK信号通路相关因子基因及蛋白影响变化及大黄灵仙方的干预作用。结果①Myd88、p-p38、TLR4、NF-κB mRNA变化情况:与空白组比较,L组、L+P组、L+S组、L+P+S组的各指标,均增加明显,剩余各组则降低明显,差异均具统计学意义(P<0.05)。与L组比较,L+P组、L+S组、L+P+S组的各指标有所降低,但差异无统计学意义(P>0.05),L+T组、L+P+T组、L+S+T组、L+P+S+T组则降低明显,差异均具统计学意义(P<0.05);与L+T组比较,L+P+T组、L+S+T组、L+P+S+T组的各指标有所降低,差异无统计学意义(P>0.05)。②Myd88、p-p38、TLR4、NF-κB蛋白变化情况:变化趋势与mRNA相同。结论大黄灵仙方可有效逆转胆管细胞炎性反应过程中存在的TLR4/NF-κB/MAPK信号通路相关因子及蛋白表达异常现象,其机制可能与NF-κB、MAPK信号阻断有关。 Objective To observe the effect of Dahuang Lingxian Formula(大黄灵仙方)regulating and controlling TLR4/NF-κB/MAPK signaling pathway related factor genes and discuss inflammatory response of bile duct cells.Methods We adopted inject LPS in rat choledochal duct to structure bile duct chronic inflammatory condition of primary bile duct stone,took rat intrahepatic bile duct endothelial cells and got through qPCR technic combined with signaling pathway blocker to observe the changes of bile duct cells'TLR4/NF-κB/MAPKsignaling pathway related factor protein and gene expression under inflammatory state and Dahuang Lingxian Formula's intervention effect.Result①Gene expressions of Myd88,p-p38,TLR4 and NF-κB:Compared with those of the blank group,those in L group,L+P group,L+S group and L+P+S group were all obviously increased.Those in L+T group,L+P+T group,L+S+T group and L+P+S+T group were obviously decreased.The difference all had statistical significance(P<0.05).Compared with those of the L group,protein and gene expressions of Myd88,p-p38,TLR4 and NF-κB in L+P group,L+S group and L+P+S group were all decreased,but had no obvious difference(P>0.05).Those in L+T group,L+P+T group,L+S+T group and L+P+S+T group were obviously decreased.The difference all had statistical significance(P<0.05).Compared with those in L+T group,protein and gene expressions of Myd88,p-p38,TLR4 and NF-κB in L+P+T group,L+S+T group and L+P+S+T group were all decreased,but had no obvious difference(P>0.05).②Protein expressions of Myd88,p-p38,TLR4 and NF-κB:The change trend was the same as mRNA.Conclusion Dahuang Lingxian Formula can effectively reverse TLR4/NF-κB/MAPK signaling pathway related factors and proteins in the process of cholangiocyte inflammatory response.The mechanism may be related to NF-κB and MAPK signal blocking.
作者 张曼 戴建业 张齐 唐乾利 俞渊 黄欣 何晓微 陈金梅 ZHANG Man;DAI Jianye;ZHANG Qi;TANG Qianli;YU Yuan;HUANG Xin;HE Xiaowei;CHEN Jinmei(Hunan University of Chinese Medicine,Changsha 410208,Changsha,China;The First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530023,Guangxi,China;Guangxi University of Chinese Medicine,Nanning 530001,Guangxi,China;Youjiang Medical University for Nationalities,Baise 533000,Guangxi,China)
出处 《中华中医药学刊》 CAS 北大核心 2021年第11期20-24,I0020,共6页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金地区科学基金(81760870) 广西自然科学基金面上项目(2018JJA140857) 广西科学研究与技术开发计划(重点研发计划)(桂科AB17195071) 广西科学研究与技术开发计划(桂科AD17129025) 广西一流学科建设开放课题项目(2019XK062,2019XK068) 广西特聘专家专项基金(桂人才通字[2019]13号)。
关键词 大黄灵仙方 TLR4/NF-κB/MAPK信号通路 胆管细胞 炎性反应 基因表达 蛋白表达 Dahuang Lingxian Formula(大黄灵仙方) TLR4/NF-κB/MAPK signaling pathway bile duct cells inflammatory response gene expression protein expression
  • 相关文献

参考文献7

二级参考文献72

  • 1孙传兴.临床疾病诊断依据治愈好转标准,第2版[M].北京:人民军医出版社,1998.163.
  • 2陆焕清.威灵仙治疗胆石症临床疗效和实验观察[J].河南中医,1987,(6):22-23.
  • 3姚育修 齐兆生 等.肝硬变与胆管结石.腹部外科临床实践[M].北京:中国医药科技出版社,1996.397.
  • 4俞渊,唐乾利,赫军,黄名威,王清坚,关中正.慢性肝损伤家兔胆石症模型制作及成石因素研究[J].中国医药导报,2007,4(12S):106-108. 被引量:14
  • 5Coban G,Yildirim E,Gokturk S,et al.Body mass index,cholecystitis,cholelithiasis,pancreatitis and imaging of common bile duct stones[J].Am J Med Sci,2014,347(5):364-369.
  • 6Migita M,Kumasaka S,Matsumoto T,et al.Cholelithiasis in a patient with type 2Gaucher disease[J].J Nippon Med Sch,2014,81(1):40-42.
  • 7Tzovaras G, Baloyiannis I, Zachari E, et al. Laparoendo- scopic rendezvous versus preoperative ERCP and laparo- scopic cholecystectomy for the management of choleeysto- choledo-cholithiasis: interim analysis of a controlled ran- domized trial[ J ]. Annals of Surgery, 2012,255 ( 3 ) : 435 -439.
  • 8Spelsberg FW, Nusser F, Huttl TK, et al. Management of cholecysto-and choledocholitiasis-survey and analysis of 16615 cholecystectomies and common bile duct explorations in Bavaria [ J ] .Zentralbl Chit, 2009,134 (2) : 120- 126.
  • 9唐乾利.胆石症术后残留及复发的中医治疗近况[J].河北中西医结合杂志,1997,6(4):535-537. 被引量:2
  • 10Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Long-term fol- low-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome:an analysis of risk factors predicting stone re- currence[J]. Surg End Other Int Tech,2011,25(7) :2179- 2185.

共引文献133

同被引文献68

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部